Android app Apple app link

Bristol Myers Squibb Clears Key Benchmark, Hitting 80-Plus RS Rating

By Investor's Business Daily   |   1 month ago
Bristol Myers Squibb Clears Key Benchmark, Hitting 80-Plus RS Rating

Focus on stocks with an RS Rating of 80 or higher for your watchlist. Bristol Myers Squibb (BMY) now has an RS Rating of 83, indicating market leadership potential. Look for a proper buy point as the stock forms and breaks out of a chart pattern.

Read More

Did you find this insightful?

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.